Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 1.00 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.75 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.75 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.75 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.75 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.75 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.75 |
| ▸ | FAAH | O00519 | 4/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | CES2 | O00748 | 3/20 | 0.56 |
| ▸ | CES1 | P23141 | 3/20 | 0.56 |
| ▸ | PPARG | P37231 | 4/20 | 0.54 |
| ▸ | PPARD | Q03181 | 4/20 | 0.54 |
| ▸ | PPARA | Q07869 | 4/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL572646 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL2403692 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL1290964 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL331039 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL4155670 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL7945790 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL23203038 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL5575814 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL20915286 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL20602650 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250297134-A1 | HIGH RATE BULK OXIDE CMP COMPOSITION | ENTEGRIS, INC. | 2025-09-25 | — | — | US | claimed |
| US-12415904-B2 | Biobased glyceryl heptanoate ester compositions and methods of making and using the same | INOLEX INVESTMENT CORPORATION (US) | 2025-09-16 | — | — | US | claimed |
| CN-118045023-A | Tear-pulled facial mask and preparation method thereof | 广东柏俐臣生物科技有限公司 | 2024-05-17 | — | — | CN | claimed |
| CN-117982377-A | Anti-wrinkle tightening composition and application thereof in cosmetics | 广州柏为科技有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-117643546-A | Ultra-low viscosity element Yan Penwu and preparation method thereof | 广东柏俐臣生物科技有限公司 | 2024-03-05 | — | — | CN | claimed |
| CN-117582394-A | Multi-effect composition for sensitive skin of adult and liquid crystal structure special cream and preparation method thereof | 天津郁美净集团有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-115364010-B | Rosemary amino acid shampoo and preparation method thereof | 河南迷迭香生物科技有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-116807940-A | Acne-removing composition, acne-removing essence and preparation method of acne-removing essence | 彭氏(惠州)实业发展有限公司 | 2023-09-29 | — | — | CN | claimed |
| EP-4240314-A1 | BIOBASED GLYCERYL HEPTANOATE ESTER COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Inolex Investment Corporation (US) | 2023-09-13 | — | — | EP | claimed |
| CN-116158984-A | Attapulgite mud film and preparation method thereof | 白银新大孚科技化工有限公司 | 2023-05-26 | — | — | CN | claimed |
| US-5328626-A | Extraction of metals from aqueous solutions | MET-TECH SYSTEMS, LTD. (CA) | 1994-07-12 | — | — | US | claimed |
| EP-0598747-A1 | N-ETHYL HYDROXAMIC ACID CHELANTS. | MONSANTO CO (US) | 1994-06-01 | — | — | EP | claimed |
| WO-1993002047-A1 | N-ETHYL HYDROXAMIC ACID CHELANTS | MONSANTO COMPANY (US) | 1993-02-04 | — | — | WO | claimed |
| US-5174917-A | Compositions containing n-ethyl hydroxamic acid chelants | MONSANTO COMPANY (US) | 1992-12-29 | — | — | US | claimed |
| US-4943646-A | WITH N-ORGANOHYDROXAMIC ACID | MONSANTO COMPANY (US) | 1990-07-24 | — | — | US | claimed |
| EP-0344143-A2 | Gallium purification | MONSANTO COMPANY (US) | 1989-11-29 | — | — | EP | claimed |
| EP-0283740-A2 | Oxidative dissolution of gallium arsenide and separation of gallium from arsenic | MONSANTO COMPANY (US) | 1988-09-28 | — | — | EP | claimed |
| US-4759917-A | Contacting with oxidizing agent and hydroxamic acid to convert gallium to gallium-hydroxamic acid complex, and oxidize arsanic | MONSANTO COMPANY (US) | 1988-07-26 | — | — | US | claimed |
| EP-0271468-A2 | Gallium complexes and solvent extraction of gallium | Monsanto Company (US) | 1988-06-15 | — | — | EP | claimed |
| US-4741887-A | Gallium complexes and solvent extraction of gallium | MONSANTO COMPANY (US) | 1988-05-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12415904-B2 | Biobased glyceryl heptanoate ester compositions and methods of making and using the same | SGMS1, MGLL, CCL11 | HSP90AA1 1742/4885HDAC3 3593/4885HDAC1 3853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.